In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library

Biochemical and Biophysical Research Communications

Volumn 342, Issue 3, 2006, Pages 956-962

  Du, Bing ^a   Qian, Min ^a,b   Zhou, Zhongliang ^a   Wang, Peng ^a   Wang, Lei ^a   Zhang, Xiaoping ^a   Wu, Miao ^a   Zhang, Ping ^a   Mei, Bing ^a  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; In vitro; Phage display library; Targeting peptides

Indexed keywords

PEPTIDE; PEPTIDE LIBRARY; PEPTIDE WP05; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIVER CANCER; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; SCID MOUSE;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; INJECTIONS; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING;

ANIMALIA;

EID: 33644620264     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.050     Document Type: Article

References (20)

1. O.H. Aina, T.C. Sroka, M.L. Chen, and K.S. Lam Therapeutic cancer targeting peptides Biopolymers 66 2002 184 199
2. W. Arap, M.G. Kolonin, M. Trepel, J. Lahdenranta, M. Cardo-Vila, R.J. Giordano, P.J. Mintz, P.U. Ardelt, V.J. Yao, C.I. Vidal, L. Chen, A. Flamm, H. Valtanen, L.M. Weavind, M.E. Hicks, R.E. Pollock, G.H. Botz, C.D. Bucana, E. Koivunen, D. Cahill, P. Troncoso, K.A. Baggerly, R.D. Pentz, K.A. Do, C.J. Logothetis, and R. Pasqualini Steps toward mapping the human vasculature by phage display Nat. Med. 8 2002 121 127
3. H.M. Azzazy, and W.E. Highsmith Jr. Phage display technology: clinical applications and recent innovations Clin. Biochem. 35 2002 425 445
4. A.N. Fatehi, H.R. van den, B. Colenbrander, A.J. Daemen, H.T. van Tol, R.M. Monteiro, B.A. Roelen, and M.M. Bevers Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development Theriogenology 63 2005 872 889
5. E.J. Franssen, F. Moolenaar, D. de Zeeuw, and D.K. Meijer Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer l-lactic acid Pharm. Res. 10 1993 963 969
6. B. Gerard, and H. Bleiberg Treatment of hepatocarcinoma Curr. Oncol. Rep. 6 2004 184 191
7. R.K. Jain The next frontier of molecular medicine: delivery of therapeutics Nat. Med. 4 1998 655 657
8. H.B. Luo, S.G. Zheng, P. Zhu, and N. Fu Study on mimotopes of E.coli lipopolysaccharide 2630 Xi. Bao. Yu Fen. Zi. Mian. Yi. Xue. Za Zhi. 20 2004 682 685
9. M. Nicolo, A. Biro, F. Cardillo-Piccolino, P. Castellani, A. Giovannini, C. Mariotti, M. Zingirian, D. Neri, and L. Zardi Expression of extradomain-B-containing fibronectin in subretinal choroidal neovascular membranes Am. J. Ophthalmol. 135 2003 7 13
10. F. Nilsson, L. Tarli, F. Viti, and D. Neri The use of phage display for the development of tumour targeting agents Adv. Drug Deliv. Rev. 43 2000 165 196
11. A. Otte, J. Mueller-Brand, S. Dellas, E.U. Nitzsche, R. Herrmann, and H.R. Maecke Yttrium-90-labelled somatostatin-analogue for cancer treatment Lancet 351 1998 417 418
12. P. Pisani, D.M. Parkin, F. Bray, and J. Ferlay Estimates of the worldwide mortality from 25 cancers in 1990 Int. J. Cancer 83 1999 18 29
13. G.K. Rajarao, N. Nekhotiaeva, and L. Good The signal peptide NPFSD fused to ricin A chain enhances cell uptake and cytotoxicity in Candida albicans Biochem. Biophys. Res. Commun. 301 2003 529 534
14. M.S. Sachdeva Drug targeting systems for cancer chemotherapy Expert Opin. Invest. Drugs 7 1998 1849 1864
15. G.P. Smith Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1985 1315 1317
16. V.P. Torchilin Drug targeting Eur. J. Pharm. Sci. 11 Suppl. 2 2000 S81 S91
17. M. Trepel, W. Arap, and R. Pasqualini In vivo phage display and vascular heterogeneity: implications for targeted medicine Curr. Opin. Chem. Biol. 6 2002 399 404
18. M. Wikman, A.C. Steffen, E. Gunneriusson, G.P. Adams, J. Carlsson, and S. Stahl Selection and characterization of HER2/neu-binding affibody ligands Protein Eng. Des. Sel. 2004
19. M.Y. Xu, X.H. Xu, G.Z. Chen, X.L. Deng, J. Li, X.J. Yu, and M.Z. Chen Production of a human single-chain variable fragment antibody against esophageal carcinoma World J. Gastroenterol. 10 2004 2619 2623
20. J. Zhang, H. Spring, and M. Schwab Neuroblastoma tumor cell-binding peptides identified through random peptide phage display Cancer Lett. 171 2001 153 164